JPRN-jRCTs051180055已完成未知
anthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia - LAVALIER
Sakaguchi Yusuke0 个研究点目标入组 40 人开始时间: 2019年2月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
We did not find a significant difference between lanthanum carbonate and calcium carbonate in the progression of coronary artery calcification during 1-year study period among patients with CKD.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) 20 Years and older (2) Hyperphosphatemia (For patients without calcium carbonate, 4.5- mg/dL) (For Patients with calcium carbonate, 4.0- mg/dL) (3) With written informed consent
排除标准
- •(1) History of cardiac surgery and/or coronary artery stenting (2) Polycystic kidney disease (3) Hypothyroidism (4) On treatment with lanthanum carbonate (5) History of admission within 3 months (6) History of ileus (7) Severe gastrointestinal dysfunction (8) Severe liver dysfunction (9) Allergy to lanthanum carbonate or calcium carbonate (10) Pregnant or breastfeeding women (11) Judged as ineligible by primary physicians
研究者
相似试验
已完成
不适用
anthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemiapre-dialysis CKDJPRN-UMIN000035527Department of Nephrology, Osaka University Hospital60
Unknown
4 期
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and HyperphosphatemiaRenal Insufficiency, ChronicBone Diseases, MetabolicHyperphosphatemiaNCT02237534Osaka University60
已完成
4 期
Comparison of hypercalcemia between lanthanum carbonate and calcium carbonate in hyperphosphatemia patients on dialysis; a cross-over studyJPRN-UMIN000002331niversity of Miyazaki hospital40
已完成
4 期
anthanum carbonate impacts on calcification regulating factors in chronic kidney diseaseJPRN-UMIN000013978Department of Medicine, Kidney Center, Tokyo Women's Medical University60
已完成
3 期
Outcome study of Lanthanum Carbonate compared with Calcium carbonate on cardiovascular mortality and morbidity in patients with chronic kidney disease on hemodialysis: Landmark StudyHemodialysis patients with hyperphosphatemiaJPRN-UMIN000006815andmark Study Group2,347